Christopher Hix Biography and Net Worth

CFO of Colfax

Chris Hix’s career includes M&A, operating and financial roles that shaped and improved global diversified public companies.

Before joining Colfax in 2016, Mr. Hix was the CFO of OM Group from 2012 until the sale of the company. He was the CFO of Robbins & Myers from 2006 to 2011, contributing to its growth and significantly improved financial performance before the sale of the company. Mr. Hix worked for 13 years in a variety of roles at Roper Technologies from pre-IPO to MidCap attainment including leading corporate M&A. He earned his MBA from St. Mary’s College and his BS in business from the University of Southern California.

What is Christopher M. Hix's net worth?: The estimated net worth of Christopher M. Hix is at least $0.00 as of March 4th, 2024. Mr. Hix owns 33,863 shares of Colfax stock worth more than $0 as of April 23rd. This net worth approximation does not reflect any other investments that Mr. Hix may own. Learn More about Christopher M. Hix's net worth.
How do I contact Christopher M. Hix?: The corporate mailing address for Mr. Hix and other Colfax executives is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. Colfax can also be reached via phone at (302) 252-9160 and via email at [email protected]. Learn More on Christopher M. Hix's contact information.
Has Christopher M. Hix been buying or selling shares of Colfax?: Christopher M. Hix has not been actively trading shares of Colfax within the last three months. Most recently, Christopher M. Hix sold 31,207 shares of the business's stock in a transaction on Monday, February 28th. The shares were sold at an average price of $40.52, for a transaction totalling $1,264,507.64. Learn More on Christopher M. Hix's trading history.
Who are Colfax's active insiders?: Colfax's insider roster includes Christopher Hix (CFO), Shyam Kambeyanda (EVP), Patricia Lang (SVP), Jason Maclean (SVP), Douglas Pitts (Insider), Daniel Pryor (EVP), Mitchell Rales (Director), Brady Shirley (CEO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Colfax's active insiders.

Christopher M. Hix Insider Trading History at Colfax

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/28/2022	Sell	31,207	$40.52	$1,264,507.64
2/25/2022	Sell	2,079	$42.18	$87,692.22
2/23/2022	Sell	1,917	$41.83	$80,188.11
12/14/2021	Sell	4,345	$44.33	$192,613.85
6/14/2021	Sell	90,000	$45.89	$4,130,100.00	182,800
3/10/2021	Sell	18,206	$46.74	$850,948.44	81,522
2/25/2021	Sell	2,007	$46.01	$92,342.07	69,955
12/14/2020	Sell	4,483	$37.41	$167,709.03	59,449
7/2/2020	Sell	6,719	$28.24	$189,744.56	66,986
7/2/2019	Sell	4,750	$27.08	$128,630.00	29,841

Christopher M. Hix Buying and Selling Activity at Colfax

Colfax Company Overview

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Today's Range

Now: N/A

50 Day Range

MA: $110.71

$39.06

$127.50

2 Week Range

Now: N/A

Volume

101,542 shs

Average Volume

1,387,519 shs

Market Capitalization

$6.30 billion

P/E Ratio

84.91

Dividend Yield

N/A

Beta

2.12

How to camouflage a factory of 53,000 workers

From Stansberry Research | Ad

Get the full story here.